bIAP

DRUG3 trials

Sponsors

AM-Pharma, Catharina Ziekenhuis Eindhoven, Imperial College London

Conditions

Bacterial Infections and MycosesCoronary Artery DiseaseDiabetes Mellitus, Type 1Endotoxin-mediated Complications From Cardiopulmonary Bypass SurgerySepsis

Phase 2

A Study in Sepsis Patients With Renal Failure

TerminatedNCT00511186

AM-PharmaBacterial Infections and Mycoses, Sepsis

Start: 2008-05-31End: 2009-12-31Updated: 2012-04-02

Phase 3

Efficacy and Safety Study on bIAP

CompletedNCT01010724

Catharina Ziekenhuis EindhovenCoronary Artery Disease, Endotoxin-mediated Complications From Cardiopulmonary Bypass Surgery

Updated: 2009-11-10

Unknown Phase

The Bio-Inspired Artificial Pancreas for the Home

TerminatedNCT03740698

Imperial College LondonDiabetes Mellitus, Type 1

Start: 2021-02-01End: 2022-01-31Updated: 2024-02-05

Related Papers

Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial.

2012-01-23141 citations